PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.09
Similar ESG score to MCRB's 59.91. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
56.82
Environmental score 1.1-1.2x MCRB's 53.79. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
57.54
Social score 80-90% of MCRB's 65.21. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.92
Similar governance score to MCRB's 60.73. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.